Design of advanced
contact lenses (CLs) demands materials that
are safe and comfortable for the wearers and that preserve the normal
eye microbiota, avoiding chronic inflammation and biofilm development.
This work aimed to combine the natural antibiofouling phosphorylcholine
and the antioxidant and prebiotic resveratrol as integral components
of CLs that may have the additional performance of preventing oxidative-stress
related eye diseases. Different from previous uses of 2-methacryloyloxyethyl
phosphorylcholine (MPC) as coating, we explored the feasibility of
adding MPC at high proportions as a comonomer of 2-hydroxyethyl methacrylate
(HEMA)-based hydrogels while still allowing for the loading of the
hydrophobic resveratrol. Homogeneous distribution of MPC along the
hydrogel depth (confirmed by Raman spectroscopy) notably increased
solvent uptake and the proportion of free water while it decreased
Young’s modulus. Relevantly, MPC did not hinder the uptake
of resveratrol by CLs (>10 mg/g), which indeed showed network/water
partition coefficients of >100. Protocols for CLs sterilization
and
loading of resveratrol under aseptic conditions were implemented,
and the effects of tear proteins on resveratrol release rate were
investigated. CLs sustained resveratrol release for more than 24 h in vitro, and sorption of albumin onto the hydrogel, although
attenuated by MPC, slowed down the release. The combination of MPC
and resveratrol reduced P. aeruginosa and S. aureus growth as tested in a novel hydrogel disk-agar
interface biofilm growth setup. The developed CLs showed excellent
anti-inflammatory properties and biocompatibility in in ovo and rabbit tests and provided higher and more prolonged levels of
resveratrol in tear fluid, which favored resveratrol biodistribution
in anterior and posterior eye segments compared to eye drops. Correlations
between the release profiles of resveratrol in vitro and in vivo were assessed. Relevantly, the CLs
preserved the antioxidant properties of resveratrol during the entire
8 h of wearing. In sum, CLs prepared with high proportion in MPC may
help address safety and comfort requirements while having drug releasing
capabilities.